Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04503213

A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation

Longitudinal Assessment of CSF1R-Related Leukoencephalopathy Following Stem Cell Transplantation

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to measure the effect of Hematopoietic Stem Cell Transplantation (HSCT) on symptoms of CSF1R-related Leukoencephalopathy.

Detailed description

The purpose of this study is to measure the effect of Hematopoietic Stem Cell Transplantation (HSCT) on symptoms of CSF1R-related Leukoencephalopathy.

Conditions

Timeline

Start date
2020-07-21
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2020-08-07
Last updated
2026-01-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04503213. Inclusion in this directory is not an endorsement.